September 7th 2024
Collaboration between technology providers and biopharma manufacturers are enabling both evolutionary and novel developments.
The authors evaluated the potential of direct filtration for multiple biopharmaceutical candidates. This article is Part 2 of the study.
Vetter Embarks on 300-Million Euro Manufacturing Expansion
October 1st 2015Vetter plans to invest approximately 300 million Euros during the course of five years to expand drug product manufacturing and logistic services in Germany; upgrades will include an improved RABS system for aseptic processing.